#bupe

Key Highlights The Drug Enforcement Administration and the Department of Health and Human Services have extended temporary flexibilities for prescribing buprenorphine via telemedicine. This is the fourth extension, set to expire in December 2026, aimed at avoiding a “telemedicine cliff.” The extension ensures continuity of care for patients with opioid use disorder and addresses the ongoing…

In January of 2022, an emergency medicine resident collaborated with an addiction medicine medical director to consider the possibility of micro-induction when presented with a unique opportunity to establish a patient on buprenorphine from an urgent care center. The multidisciplinary team previously established a buprenorphine/naloxone sublingual (BUP/NX SL) micro-induction for outpatient protocol* for clinical implementation and successful utilization across campuses and with Southern New Jersey Medication for Addiction Treatment Center of Excellence (MATCOE) networks.

*To support buprenorphine prescribers who may often find themselves sketching the micro-induction process for patients, the addiction medicine content manager designed health communication material outlining the aforementioned protocol for micro-induction in the outpatient setting, in addition to adjunctive medications. The protocol is featured in a manuscript, authored by the content manager and clinical team, and submitted for peer review and publication. Learn more here.

Recommended citation:

$4.7m of bupe siezed by drug squad

Detectives from the Major Drug Squad have arrested two people over the past week and seized a range of drugs as part of an investigation into the trafficking of 1,4 butanediol, commonly known as ‘bupe’ in Melbourne. Police executed a warrant at a residential property on Albion Road, Box Hill this morning and arrested a 27-year-old Box Hill man. He is currently being interviewed and expected to be…